Detalles de la búsqueda
1.
An experience- and preference-based EQ-5D-3L value set derived using 18 months of longitudinal data in patients who sustained a fracture: results from the ICUROS.
Qual Life Res
; 32(4): 1199-1208, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36495384
2.
Quality of life after hip, vertebral, and distal forearm fragility fractures measured using the EQ-5D-3L, EQ-VAS, and time-trade-off: results from the ICUROS.
Qual Life Res
; 27(3): 707-716, 2018 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-29235059
3.
Treatment patterns, health care utilization, and costs of ovarian cancer in Central and Eastern Europe using a Delphi panel based on a retrospective chart review.
Int J Gynecol Cancer
; 23(5): 823-32, 2013 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-23666016
4.
Identifying Predictors of First-Line Subcutaneous TNF-Inhibitor Persistence in Patients with Inflammatory Arthritis: A Decision Tree Analysis by Indication.
Adv Ther
; 40(10): 4657-4674, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37599341
5.
Heterogeneity in Survival with Immune Checkpoint Inhibitors and Its Implications for Survival Extrapolations: A Case Study in Advanced Melanoma.
MDM Policy Pract
; 7(1): 23814683221089659, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35356551
6.
Socioeconomic cost of AML in Sweden-A population-based study using multiple nation-wide registers.
EJHaem
; 2(3): 385-393, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35844713
7.
Potentiation of chemotherapeutic drugs by energy metabolism inhibitors 2-deoxyglucose and etomoxir.
Int J Cancer
; 123(2): 476-483, 2008 Jul 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-18452174
8.
Induction of mitochondrial dysfunction as a strategy for targeting tumour cells in metabolically compromised microenvironments.
Nat Commun
; 5: 3295, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24548894
9.
The phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 is effective in inhibiting regrowth of tumour cells after cytotoxic therapy.
Eur J Cancer
; 48(3): 396-406, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-22154651
10.
Cisplatin-induced nitrosylation of p53 prevents its mitochondrial translocation.
Free Radic Biol Med
; 46(12): 1607-13, 2009 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-19328230
11.
Ovarian carcinoma cells with low levels of beta-F1-ATPase are sensitive to combined platinum and 2-deoxy-D-glucose treatment.
Mol Cancer Ther
; 8(7): 1916-23, 2009 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-19567816
12.
Conditional drug screening shows that mitotic inhibitors induce AKT/PKB-insensitive apoptosis.
J Chem Biol
; 2(2): 81-7, 2009 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-19568785
13.
Cisplatin and oxaliplatin toxicity: importance of cochlear kinetics as a determinant for ototoxicity.
J Natl Cancer Inst
; 101(1): 37-47, 2009 Jan 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-19116379
14.
3-Bromopyruvate as inhibitor of tumour cell energy metabolism and chemopotentiator of platinum drugs.
Mol Oncol
; 2(1): 94-101, 2008 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-19383331
15.
Two distinct steps of Bak regulation during apoptotic stress signaling: different roles of MEKK1 and JNK1.
Exp Cell Res
; 312(9): 1581-9, 2006 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-16529740
Resultados
1 -
15
de 15
1
Próxima >
>>